Beer Polyphenols and Menopause: Effects and Mechanisms - A Review of Current Knowledge

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Sandoval Ramírez, Berner Andrée ^a   Lamuela Raventós, Rosa M ^a,b   Estruch, Ramon ^a,b   Sasot, Gemma ^a,b   Doménech, Monica ^a,b   Tresserra Rimbau, Anna ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION; HEALTH RISKS; MODULATION; RISK ASSESSMENT;

CARDIOVASCULAR RISK; DIRECT INTERACTIONS; FERMENTED BEVERAGES; HORMONE REPLACEMENT THERAPY; MENOPAUSAL SYMPTOMS; PHENOLIC COMPOUNDS; PLASMA CONCENTRATION; SCIENTIFIC EVIDENCE;

BEER;

3 HYDROXYBENZOIC ACID; 4 HYDROXYBENZOIC ACID; 8 PRENYLNARINGENIN; APIGENIN; AURANTIIN; BIOCHANIN A; CATECHIN; CHALCONE DERIVATIVE; DAIDZEIN; EPICATECHIN; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOL DERIVATIVE; GALLIC ACID; GENISTEIN; GENTISIC ACID; HYDROXYBENZOIC ACID DERIVATIVE; ISOFLAVONOID; ISOXANTHOHUMOL; MYRICETIN; POLYPHENOL; PROCYANIDIN DERIVATIVE; PROTOCATECHUIC ACID; QUERCETIN; RUTOSIDE; SALICYLIC ACID; SYRINGIC ACID; VANILLIC ACID; XANTHOHUMOL;

ALCOHOL CONSUMPTION; ARTICLE; BEER; CARDIOVASCULAR RISK; HORMONE BLOOD LEVEL; HUMAN; MENOPAUSE; OSTEOPOROSIS; VASOMOTOR DISORDER; ANALYSIS; BLOOD; DRUG EFFECT; FEMALE; HEALTH; METABOLOME; PHYSIOLOGY;

CHEMICAL COMPOUNDS; DISEASES; PHENOLS;

BEER; FEMALE; HEALTH; HUMANS; MENOPAUSE; METABOLOME; POLYPHENOLS;

EID: 85028634916     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/4749131     Document Type: Article

References (72)

1. World Health Organization, Alcohol in the European Union. Consumption, Harm and Policy Approaches, World Health Organization, Regional office for Europe, Copenhaguen, Denmark, 2012.
2. M. Adjemian and R. Volpe, Alcohol consumption and food-athome dietary quality in the United States, Journal of Wine Economics. 2012 Annual Meeting, August 12-14, Agricultural and Applied Economics Association, Seattle, Washington, WA, USA, 2012.
3. W. Jiajing, L. Li, B. Terry, Y. Linjie, L. Yuanqing, and X. Fulai, "Revealing a 5,000-y-old beer recipe in China," Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 23, pp. 6444-6448, 2016.
4. R. W. Unger, Beer in the Middle Ages and the Renaissance Philadelphia, University of Pennsylvania Press, Philadelphia, PA, USA, 2007.
5. L. C. Nogueira, R. F. do Rio, P. C. Lollo, and I. M. Ferreira, "Moderate alcoholic beer consumption: the effects on the lipid profile and insulin sensitivity of adult men," Journal of Food Science, vol. 82, no. 7, pp. 1720-1725, 2017.
6. C. Matsumoto, M. D. Miedema, P. Ofman, J. M. Gaziano, and H. D. Sesso, "An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease," Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 34, no. 3, pp. 159-171, 2014.
7. S. Arranz, G. Chiva-Blanch, P. Valderas-Martínez, A. Medina-Remón, R. M. Lamuela-Raventós, and R. Estruch, "Wine, beer, alcohol and polyphenols on cardiovascular disease," Nutrients, vol. 4, no. 7, pp. 759-781, 2012.
8. A. Hernandez-Hernandez, A. Gea, M. Ruiz-Canela et al., "Mediterranean alcohol-drinking pattern and the incidence of cardiovascular disease and cardiovascular mortality: the SUN project," Nutrients, vol. 7, no. 11, pp. 9116-9126, 2015.
9. G. Chiva-Blanch, E. Magraner, X. Condines et al., "Effects of alcohol and polyphenols from beer on atherosclerotic biomarkers in high cardiovascular risk men: a randomized feeding trial," Nutrition, Metabolism, and Cardiovascular Diseases, vol. 25, no. 1, pp. 36-45, 2015.
10. A. Di Castelnuovo, S. Costanzo, R. di Giuseppe, G. de Gaetano, and L. Iacoviello, "Alcohol consumption and cardiovascular risk: mechanisms of action and epidemiologic perspectives," Future Cardiology, vol. 5, no. 5, pp. 467-477, 2009.
11. T. Brügger-Andersen, V. Pönitz, S. Snapinn, and K. Dickstein, "Moderate alcohol consumption is associated with reduced long-term cardiovascular risk in patients following a complicated acute myocardial infarction," International Journal of Cardiology, vol. 133, no. 2, pp. 229-232, 2009.
12. J. A. Rothwell, J. Pérez-Jiménez, V. Neveu et al., "Phenolexplorer 3.0: a major update of the phenol-explorer database to incorporate data on the effects of food processing on polyphenol content," Database: The Journal of Biological Databases and Curation, vol. 2013, 2013.
13. K. Annekathrin, Z. Oliver, and K. Georg, "Hop extracts and hop substances in treatment of menopausal complaints," Planta Medica, vol. 79, no. 7, pp. 576-579, 2013.
14. A. Fatemeh, M. Hamid, and R. Nasibeh, "Hops for menopausal vasomotor symptoms: mechanisms of action," Journal of Menopausal Medicine, vol. 22, no. 2, pp. 62-64, 2016.
15. J. Pedrera-Zamorano, J. Lavado-Garcia, R. Roncero-Martin, J. Calderon-Garcia, T. Rodriguez-Dominguez, and M. Canal-Macias, "Effect of beer drinking on ultrasound bone mass in women," Nutrition, vol. 25, no. 10, pp. 1057-1063, 2009.
16. A. W. Taylor, E. Barofsky, J. A. Kennedy, and M. L. Deinzer, "Hop (Humulus lupulus L.) proanthocyanidins characterized by mass spectrometry, acid catalysis, and gel permeation chromatography," Journal of Agricultural and Food Chemistry, vol. 51, no. 14, pp. 4101-4010, 2013.
17. P. Quifer-Rada, A. Vallverdú-Queralt, M. Martínez-Huélamo et al., "A comprehensive characterisation of beer polyphenols by high resolution mass spectrometry (LC-ESI-LTQOrbitrap-MS)," Food Chemistry, vol. 169, pp. 336-343, 2015.
18. D. Intelmann, G. Haseleu, and T. Hofmann, "LC-MS/MS quantitation of hop-derived bitter compounds in beer using the ECHO technique," Journal of Agricultural and Food Chemistry, vol. 57, no. 4, pp. 1172-1182, 2009.
19. J. E. Hall, "Neuroendocrine physiology of the early and late menopause," Endocrinology and Metabolism Clinics of North America, vol. 33, no. 4, pp. 637-659, 2004.
20. A. Ziv-Gal and J. A. Flaws, "Factors that may influence the experience of hot flushes," Journal of Women's Health, vol. 19, no. 10, pp. 1905-1914, 2010.
21. F. Kronenberg, "Menopausal hot flashes: a review of physiology and biosociocultural perspective on methods of assessment," The Journal of Nutrition, vol. 140, no. 7, pp. 1380S-1385S, 2010.
22. D. De Keukeleire, L. De Cooman, H. Rong, A. Heyerick, J. Kalita, and S. R. Milligan, "Functional properties of hop polyphenols," Basic Life Sciences, vol. 66, pp. 739-760, 1999.
23. C. Gerhauser, "Beer constituents as potential cancer chemopreventive agents," European Journal of Cancer, vol. 41, no. 13, pp. 1941-1954, 2005.
24. C. Leitao, E. Marchioni, M. Bergaentzlé et al., "Effects of processing steps on the phenolic content and antioxidant activity of beer," Journal of Agricoultural and Food Chemistry, vol. 59, no. 4, pp. 1249-1255, 2011.
25. M. N. Clifford, "Diet-derived phenols in plasma and tissues and their implications for health," Planta Medica, vol. 70, no. 12, pp. 1103-1114, 2004.
26. C. Cueva, I. Gil-Sánchez, B. Ayuda-Durán et al., "An integrated view of the effects of wine polyphenols and their relevant metabolites on gut and host health," Molecules, vol. 22, no. 1, 2017.
27. M. Monagas, M. Urpi-Sarda, F. Sánchez-Patán et al., "Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites," Food & Function, vol. 1, no. 3, pp. 233-253, 2010.
28. T. Requena, M. Monagas, M. Pozo-Bayón et al., "Perspectives of the potential implications of wine polyphenols on human oral and gut microbiota," Trends in Food Science & Technology, vol. 21, no. 7, pp. 332-344, 2010.
29. A. Scalbert and G. Williamson, "Dietary intake and bioavailability of polyphenols," Journal of Nutrition, vol. 130, no. 8S, pp. 2073S-2085S, 2000.
30. M. Nardini, F. Natella, C. Scaccini, and A. Chiselli, "Phenolic acids from beer are absorbed and extensively metabolized in humans," The Journal of Nutritional Biochemistry, vol. 17, no. 1, pp. 14-22, 2006.
31. R. Zamora-Ros, M. Urpi-Sarda, R. M. Lamuela-Raventós et al., "Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption," Clinical Chemistry, vol. 52, no. 7, pp. 1373-1380, 2006.
32. J. M. Hodgson, S. Y. Chan, I. B. Puddey et al., "Phenolic acid metabolites as biomarkers for tea-and coffee-derived polyphenol exposure in human subjects," The British Journal of Nutrition, vol. 91, no. 2, pp. 301-306, 2004.
33. P. Quifer-Rada, M. Martínez-Huelamo, G. Chiva-Blanch, O. Jauregui, R. Estruch, and R. M. Lamuela-Raventós, "Urinary isoxanthohumol is a specific and accurate biomarker of beer consumption," The Journal of Nutrition, vol. 144, no. 4, pp. 484-488, 2014.
34. R. A. Canccetta, K. D. Croft, L. J. Beilin, and I. B. Puddey, "Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability," American Journal of Clinical Nutrition, vol. 71, no. 1, pp. 67-74, 2000.
35. J. S. Berek, Berek and Novak's Gynecology, Lippincott Williams and Wilkins, Philadelphia, PA, USA, 15th edition, 2012.
36. M. R. Sowers, A. D. Eyvazzadeh, D. McConnell et al., "Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition," Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 9, pp. 3478-3483, 2008.
37. P. Llaneza, M. P. García-Portilla, D. Llaneza-Suárez, B. Armott, and F. R. Pérez-López, "Depressive disorders and the menopause transition," Maturitas, vol. 71, no. 2, pp. 120-130, 2012.
38. B. Hoffman, J. Schorge, J. Schaffer, L. Halvorson, K. Bradshaw, and F. Cunningham, Williams Gynecology, McGraw-Hill Medical, New York, NY, USA, 2nd edition, 2012.
39. H. Souza and G. Tezini, "Autonomic cardiovascular damage during post-menopause: the role of physical training," Aging and Disease, vol. 4, no. 6, pp. 320-328, 2013.
40. V. Malinauskiene and A. Tamosiunas, "Menopause and myocardial infarction risk among employed women in relation to work and family psychosocial factors in Lithuania," Maturitas, vol. 66, no. 1, pp. 94-98, 2010.
41. I. A. Ebong, K. E. Watson, D. C. Goff et al., "Age at menopause and incident heart failure: the multi-ethnic study of atherosclerosis," Menopause, vol. 21, no. 6, pp. 585-591, 2014.
42. E. Barrett-Connor, "Menopause, atherosclerosis, and coronary artery disease," Current Opinion in Pharmacology, vol. 13, no. 2, pp. 186-191, 2013.
43. M. Wellons, P. Ouyang, P. J. Schreiner, D. M. Herrington, and D. Vaidya, "Early menopause predicts future coronary heart disease and stroke: the multi-ethnic study of atherosclerosis," Menopause, vol. 19, no. 10, pp. 1081-1087, 2012.
44. D. McLemon, J. Powell, R. Jugdaohsingh, and H. Macdonald, "Do lifestyle choices explain the effect of alcohol on bone mineral density in women around menopause," The American Journal of Clinical Nutrition, vol. 95, no. 5, pp. 1261-1269, 2012.
45. L. Baig, F. A. Mansuri, and S. A. Karim, "Association of menopause with osteopenia and osteoporosis: results from population based study done in Karachi," Journal of the College of Physicians and Surgeons-Pakistan, vol. 19, no. 4, pp. 240-244, 2009.
46. W. H. Utian, "Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review," Health and Quality of Life Outcomes, vol. 3, no. 1, p. 47, 2005.
47. R. E. Williams, L. Kalilani, D. B. DiBenedetti, X. Zhou, S. E. Fehnel, and R. V. Clark, "Healthcare seeking and treatment for menopausal symptoms in the United States," Maturitas, vol. 58, no. 4, pp. 348-358, 2007.
48. R. R. Friedman, "Pathophysiology and treatment of menopausal hot flashes," Seminars in Reproductive Medicine Journal, vol. 23, no. 2, pp. 117-125, 2005.
49. D. C. Deecher, "Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symptoms," Expert Opinion on Investigational Drugs, vol. 14, no. 4, pp. 434-448, 2005.
50. F. Kronenberg, "Hot flashes: epidemiology and physiology," Annals of the New York Academy of Sciences, vol. 592, pp. 52-86, 1990.
51. S. R. Davis, I. Dinatale, L. Rivera-Woll, and S. Davison, "Postmenopausal hormone therapy: from monkey glands to transdermal patches," Journal of Endocrinology, vol. 185, no. 2, pp. 207-222, 2005.
52. M. S. Krause and S. T. Nakajima, "Hormonal and nonhormonal treatment of vasomotor symptoms," Obstetrics and Gynecology Clinics of North America, vol. 42, no. 1, pp. 163-179, 2015.
53. H. M. Boardman, L. Hartley, A. Eisinga et al., "Hormone therapy for preventing cardiovascular disease in post-menopausal women," The Cochrane Database of Systematic Reviews, vol. 10, no. 3, 2015.
54. C. La Vecchia, "Ovarian cancer: epidemiology and risk factors," European Journal of Cancer Prevention, vol. 26, no. 1, pp. 55-62, 2017.
55. J. D. Yang, M. F. Abdelmalek, C. D. Guy et al., "Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis," Clinical Gastroenterology and Hepatology, vol. 15, no. 1, pp. 127-131, 2017.
56. World Health Organization and International Agency for Research on Cancer. IARC, "Monographs on the evaluation of carcinogenic risks to humans: alcohol consumption and ethyl carbamate," in Monographs on the Evaluation of Carcinogenic Risks to Humans, World Health Organization, International Agency for Research on Cancer, Lyon, France, 2010, Report No.: 96.
57. R. Estruch, M. Urpi-Sarda, G. Chiva, E. S. Romero, M. I. Covas, and J. Salas-Salvadó, Cerveza, Dieta Mediterránea y Enfermedad Cardiovascular. Dossier de Prensa, Madrid, Spain, Centro de Información Cerveza y Salud, Cerveza y Salud, 2011.
58. S. Costanzo, A. Di Castelnuovo, M. B. Donati, L. Iacoviello, and W. de Gaetano, "Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis," European Journal of Epidemiology, vol. 26, no. 11, pp. 833-850, 2011.
59. L. Brown, P. Kroon, D. Das et al., "The biological responses to resveratrol and other polyphenols from alcoholic beverages," Alcoholism, Clinical and Experimental Research, vol. 33, no. 9, pp. 1513-1526, 2009.
60. M. N. Gronbaek, T. I. Sorensen, D. Johansen et al., "Beer, wine, spirits and mortality," Läkartidningen, vol. 98, no. 21, pp. 2585-2588, 2001.
61. S. Renaud, D. Lanzmann-Petithory, R. Gueguen, and P. Conard, "Alcohol and mortality from all causes," Biological Research, vol. 37, pp. 183-187, 2004.
62. K. L. Tucker, R. Jugdaohsing, J. J. Powell et al., "Effects of beer, wine, and liquor intakes on bone mineral density in older men and women," American Journal of Clinical Nutrition, vol. 89, no. 4, pp. 1188-1196, 2009.
63. P. Gresele, C. Cerletti, G. Guglielmini, P. Pignatelli, G. de Gaetano, and F. Violi, "Effects of resveratrol and other wine polyphenols on vascular function: an update," Journal of Nutritional Biochemistry, vol. 22, no. 3, pp. 202-211, 2011.
64. N. Martinez, M. Urpi-Sarda, M. A. Martinez-Gonzalez, C. Andres-Lacueva, and M. T. Mitjavila, "Dealcoholised beers reduce atherosclerosis and expression of adhesion molecules in apoE-deficient mice," British Journal of Nutrition, vol. 105, no. 5, pp. 721-730, 2011.
65. A. Piazzon, M. Forte, and M. Nardini, "Characterization of phenolics content and antioxidant activity of different beer types," Journal of Agricultural and Food Chemistry, vol. 58, no. 19, pp. 10677-10683, 2010.
66. R. Estruch, E. Sacanella, E. Badia et al., "Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers," Atherosclerosis, vol. 175, no. 1, pp. 117-123, 2004.
67. R. Erkkola, S. Vervarcke, S. Vansteelandt, P. Rompotti, D. DeKeukeleire, and A. Heyerick, "A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts," Phytomedicine, vol. 17, no. 6, pp. 389-396, 2010.
68. R. R. Friedman, "Hot flashes: behavioral treatments, mechanisms, and relation," American Journal of Medicine, vol. 118, no. 12Bf, pp. 124-130, 2005.
69. H. H. Berendsen, A. H. Weekers, and H. J. Kloosterboer, "Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats," European Journal of Pharmacology, vol. 419, no. 1, pp. 47-54, 2001.
70. J. Bowe, X. F. Li, J. Kinsey-Jones et al., "The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes," Journal of Endocrinology, vol. 191, no. 2, pp. 399-405, 2006.
71. A. Keiler, O. Zierau, and G. Kretzschmar, "Hop extracts and hop substances in treatment of menopausal complaints," Planta Medica, vol. 79, no. 7, pp. 576-579, 2013.
72. R. B. Van Breemen, Y. Yang, S. Banuvar et al., "Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops," Molecular Nutrition & Food Research, vol. 58, no. 10, pp. 1962-1969, 2014.